DOACs and LV Thrombus Management

0:00-0:42: Intro

0:43-1:53: Introduction of Dr. Kazuhiko Kido

1:54-6:02: Trial Overview

6:03-9:09: Previous Data for LV Thrombus Management

9:10-10:10: Overall Thoughts

10:11-12:44: Trial Limitations

12:45-15:01: Background Medications and LV Thrombus secondary to ischemic cardiomyopathy vs. non-ischemic cardiomyopathy

15:02-19:08: LV thrombus anticoagulation management in patients

19:09-19:54: Closing


  • Robinson AA, Trankle CR, Eubanks G, et al. Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi. JAMA Cardiol 2020;5(6):685-692.
  • Vaitkus PT, Barnathan ES. Embolic potential prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol 1993;22(4):1004-1009. doi:10.1016/0735-1097(93)90409-T.
  • Robinson A, Ruth B, Dent J. Direct oral anticoagulants compared to warfarin for left ventricular thrombi: a single center experience. J Am Coll Cardiol 2018;71(11)(suppl):A981. doi:10.1016/S0735-1097(18)31522-5
  • Cochran JM, Jai X, Hamzeh I, and Birnbaum Y. Direct oral anticoagulant use for left ventricular thrombus: a single center experience. Circulation 2018;138(suppl_1)A16411.
  • McCarthy CP, Murphy S, Venkateswaran RV, et al. Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes. J Am Coll Cardiol 2019;73(15):2007-2009. doi:10.1016/j.jacc.2019.01.031.
  • Fleddermann AM, Hayes CH, Magalski A, and Main ML. Efficacy of direct acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol 2019;124(3):367-372. doi:10.1016/j.amjcard.2019.05.009.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: